{"organizations": [], "uuid": "d56ede1dfbe32b346c88f1c2e58fd9769349e9f6", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180508.html", "section_title": "Archive News &amp; Video for Tuesday, 08 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-zynerba-pharmaceuticals-reports-q1/brief-zynerba-pharmaceuticals-reports-q1-loss-of-0-91-per-share-idUSFWN1SF0Q6", "country": "US", "domain_rank": 408, "title": "BRIEF-Zynerba Pharmaceuticals Reports Q1 Loss Of $0.91 Per Share", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.008, "site_type": "news", "published": "2018-05-08T19:30:00.000+03:00", "replies_count": 0, "uuid": "d56ede1dfbe32b346c88f1c2e58fd9769349e9f6"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-zynerba-pharmaceuticals-reports-q1/brief-zynerba-pharmaceuticals-reports-q1-loss-of-0-91-per-share-idUSFWN1SF0Q6", "ord_in_thread": 0, "title": "BRIEF-Zynerba Pharmaceuticals Reports Q1 Loss Of $0.91 Per Share", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-zynerba pharmaceuticals reports", "sentiment": "negative"}, {"name": "zynerba pharmaceuticals inc", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 8 (Reuters) - Zynerba Pharmaceuticals Inc:\n* ZYNERBA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS\n* ZYNERBA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.91\n* ZYNERBA - BELIEVES CASH, CASH EQUIVALENT POSITION OF $52.1 MILLION AS OF MARCH 31, IS SUFFICIENT TO FUND OPERATIONS, CAPITAL REQUIREMENTS INTO 2019 Source text: ( bit.ly/2IqdNOw ) Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://bit.ly/2IqdNOw", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-08T19:30:00.000+03:00", "crawled": "2018-05-09T12:20:15.009+03:00", "highlightTitle": ""}